SCHEMBL3814673

SCHEMBL3814673

O=c1cc(C=S)oc2ccccc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.63
SMN1; SMN2 Q16637 5/20 0.63
RAB9A P51151 4/20 0.63
HPGD P15428 4/20 0.63
KDM4E B2RXH2 4/20 0.63
ALDH1A1 P00352 3/20 0.63
NPSR1 Q6W5P4 2/20 0.63
MAPT P10636 2/20 0.63
TNKS O95271 6/20 0.51
PARP1 P09874 3/20 0.51
TNKS2 Q9H2K2 3/20 0.51
GABRP O00591 3/20 0.51
GABRD O14764 3/20 0.51
GABRA1 P14867 3/20 0.51
GABRB1 P18505 3/20 0.51
GABRG2 P18507 3/20 0.51
GABRB3 P28472 3/20 0.51
GABRA5 P31644 3/20 0.51
GABRA3 P34903 3/20 0.51
GABRA2 P47869 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3844010 0.83 NPC1 (0.65) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL11497113 0.81 NPC1 (0.68) NPC1SMN1; SMN2RAB9AHPGDKDM4E
Methane SCHEMBL11545753 0.77 SMN1; SMN2 (0.58) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL2465240 0.77 HPGD (1.00) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL435366 0.77 HPGD (1.00) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL24241713 0.75 KDM4E (0.63) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL8493846 0.75 HPGD (0.63) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL10615084 0.73 KDM4E (0.78) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL9976005 0.73 KDM4E (0.78) NPC1SMN1; SMN2RAB9AHPGDKDM4E
SCHEMBL9975965 0.73 KDM4E (0.78) NPC1SMN1; SMN2RAB9AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740225-A4 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING BRISTOL MYERS SQUIBB CO (US) 2009-08-19 EP disclosed
EP-1740225-A2 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING Bristol-Myers Squibb Company (US) 2007-01-10 EP disclosed
WO-2005105159-A2 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-10 WO disclosed